Dynamic Variation of Impedance Cardiography(DYVIC) as a Diagnostic Tool of Acute Heart Failure (AHF)
Study Details
Study Description
Brief Summary
Dynamic variations of bio-impedance measured cardiac output using non pharmacologic intervention (sitting position, passive leg rising and valsalva maneuver) could be used to detect acute heart failure in patients admitted to the ED for dyspnea.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Acute heart failure (AHF) is a frequent condition in emergency basis and is responsible of a big number of admissions, complications, and deaths.
despite advances in diagnostic techniques, AHF diagnosis still difficult and cost not effective.
Measurement of cardiac output (CO) is used as a way to evaluate global cardiac function and changes in CO may be used to identify a change in the hemodynamic status of a patient.
the gold standard of measuring CO is thermodilution catheterization, however this is an invasive technique that poses a risk to the patient.
Impedance cardiography (ICG) is a noninvasive method for measuring CO. it is performed by applying small electrical current to the chest, and through electrodes placed on the neck and sides.
the pulsatile flow of blood causes fluctuations in the current, and the device calculates CO from the impedance waveform.
In practice, the investigators connect the device "BIOPAC" by using four electrodes which the investigators place on the base of the neck (posterior face) and on the base of the thorax (posterior face).
The ECG recording is taken simultaneously with two other electrodes placed at the right upper limb and left lower limb.
In addition to detecting the electric current and the ECG, heart sounds are recorded using a sensor that is placed at the mitral site.
The various curves are displayed simultaneously and stored for analysis. Subjects were first placed in the semi sitting position 30°, and after 5 minutes had cardiac output measurements performed. (CO1)
A second cardiac output measurement was performed after 5 min of seated position. (C02)
Patients were then placed in the initial position, and after an additional 5 minutes had cardiac output measurements performed. (CO1')
A third set of measurement was obtained during 45° passive leg raising at 1 to 2 minutes.(CO3)
Patients were then placed in the initial position, and after an additional 5 minutes had cardiac output measurements performed. (CO1'')
During a Valsalva maneuver the investigators took the fourth cardiac output measurement. (CO4)
Patients were then placed in the initial position, and after an additional 5 minutes had cardiac output measurements performed. (CO1''')
Dynamic variations on bio-impedance measured CO using non pharmacologic intervention (sitting position, passive leg rising and Valsalva maneuver) could be used to detect AHF in patients admitted to the ED for dyspnea.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: patients with acute dyspnea patients presenting to the emergency department with acute onset dyspnea are assessed for acute heart failure using the bio impedance technology (BIOPAC system) to measure the cardiac output in different clinical situations. FIRST: the cardiac output (CO) is measured at the reference position. Inbetween each step the patient was put in the reference position during 5 minutes. |
Other: Reference position
patient is put in a 30 degree supine position during 5 minutes
Other Names:
|
| Experimental: the sitting position the patient is put at the sitting position and we measure the cardiac output by BIOPAC system (patient is put to a 90 degree sitting position during 1 to 2 minutes then the CO is measured 5 minutes later) |
Other: Reference position
patient is put in a 30 degree supine position during 5 minutes
Other Names:
Other: Valsalva maneuver
patients are asked to perform the Valsalva maneuver by executing a forced blow into a manometer for 30 seconds and the CO is calculated during this test.
Other: a passive leg rising maneuver
we make a passive leg rising and we measure the cardiac output by BIOPAC system (45 degree passive leg rising was done for 1 to 2 minutes and CO was measured during the maneuver.)
|
| Experimental: a passive leg rising maneuver we make a passive leg rising and we measure the cardiac output by BIOPAC system (45 degree passive leg rising was done for 1 to 2 minutes and CO was measured during the maneuver 5minutes later.) |
Other: Reference position
patient is put in a 30 degree supine position during 5 minutes
Other Names:
Other: sitting position
patient is put to a 90 degree sitting position during 1 to 2 minutes then the CO is measured
Other: Valsalva maneuver
patients are asked to perform the Valsalva maneuver by executing a forced blow into a manometer for 30 seconds and the CO is calculated during this test.
|
| Experimental: Valsalva maneuver the patient was asked to perform the Valsalva maneuver and we measure the cardiac output by BIOPAC system(patients are asked to perform the Valsalva maneuver by executing a forced blow into a manometer for 30 seconds and the CO is calculated during this test.) |
Other: Reference position
patient is put in a 30 degree supine position during 5 minutes
Other Names:
Other: sitting position
patient is put to a 90 degree sitting position during 1 to 2 minutes then the CO is measured
Other: a passive leg rising maneuver
we make a passive leg rising and we measure the cardiac output by BIOPAC system (45 degree passive leg rising was done for 1 to 2 minutes and CO was measured during the maneuver.)
|
Outcome Measures
Primary Outcome Measures
- Cardiac output rate measured by ICG before and during maneuvers in acute dyspneic patients between the AHF and non AHF groups [12 hours]
The diagnostic performance of each maneuver is evaluated by calculating the CO in ml/min by bio-impedance technique and compare the values between patients with and without AHF and between baseline. The diagnosis of AHF is based on clinical, biological (BNP levels), radiological (chest X-ray) and cardiac ultrasound data.
Secondary Outcome Measures
- In hospital death [up to 10 days]
survivor or ,ot
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 year old or above
-
non traumatic acute dyspnea
Exclusion Criteria:
-
age <18 years,
-
cardio respiratory arrest,
-
coma,
-
shock,
-
need for inotropic or vasoactive drugs,
-
mechanical ventilation,
-
severe and sustained rhythm disorders,
-
severe mitral valve disease,
-
severe pulmonary arterial hypertension
-
renal insufficiency with creatinine>150 μmol/l.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Emergency Department | Monastir | Tunisia | 5000 |
Sponsors and Collaborators
- University of Monastir
Investigators
- Principal Investigator: Nouira Samir, Profesor, University hospital of Monastir
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- DYVIC